封面
市場調查報告書
商品編碼
1638754

順勢療法藥物治療市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Homeopathy Medicine Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球順勢療法藥物治療市場估值為93 億美元,預計2024 年至2032 年複合年成長率為12%。其最小的副作用而受到追捧。將順勢療法融入全球(尤其是歐洲和亞洲)的醫療保健系統,為市場擴張做出了重大貢獻。此外,政府的支持性政策、順勢療法藥物的供應增加以及專科診所的不斷增加也增強了該行業的實力。

市場分為幾個產品類別,包括稀釋劑、酊劑、片劑和膠囊、顆粒劑、乳膏劑和軟膏劑、鼻噴霧劑等。其中,稀釋業務佔最大佔有率,預計在預測時間內複合年成長率為 11.9%。這個細分市場的主導地位植根於順勢療法的核心原則,順勢療法使用高度稀釋的物質來刺激身體的自然癒合機制。這些療法以其安全性和溫和的效果而聞名,對那些尋求自然療法治療需要長期治療的慢性病的人來說很有吸引力。

美國在北美順勢療法市場中佔據顯著地位,預計將保持這一領先地位,2023 年複合年成長率為11.7%。患病率推動的。受此類疾病影響的人數不斷增加,進一步擴大了順勢療法的市場,順勢療法為控制疼痛和促進整體健康提供了安全有效的選擇。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 93億美元
預測值 254億美元
複合年成長率 12%

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 對順勢療法選擇的認知不斷提高
      • 慢性病盛行率增加
      • 在新興市場越來越受歡迎
    • 產業陷阱與挑戰
      • 常規藥物和替代藥物的可用性
  • 成長潛力分析
  • 監管環境
  • 消費者行為分析
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 稀釋液
  • 酊劑
  • 片劑和膠囊
  • 顆粒劑
  • 乳霜和軟膏
  • 鼻噴劑
  • 其他產品

第 6 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 鎮痛解熱
  • 胃腸病學
  • 呼吸系統
  • 神經病學
  • 皮膚科
  • 其他應用

第 7 章:市場估計與預測:按來源分類,2021 - 2032 年

  • 主要趨勢
  • 植物性
  • 礦物基
  • 以動物為基礎

第 8 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 處方
  • 場外交易

第 9 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章:公司簡介

  • A Nelson & Co
  • Ainsworths
  • Bahola
  • Biologische Heilmittel
  • BJain Pharmaceuticals
  • Boiron
  • Dr. Willmar Schwabe
  • Hahnemann Laboratories
  • Heel
  • Hevert - Arzneimittel
  • Homeocan
  • Medisynth
  • Powell Laboratories
  • SBL
  • Wheezal Homoeo Pharma
簡介目錄
Product Code: 12127

The Global Homeopathy Medicine Treatment Market was valued at USD 9.3 billion in 2023 and is projected to expand at a CAGR of 12% from 2024 to 2032. This robust growth is driven by the increasing preference for homeopathic treatments, which are sought after for their minimal side effects and natural approach to healing.Rising awareness about the effectiveness of homeopathy in managing chronic and lifestyle-related conditions is a key factor fueling market growth. The integration of homeopathic practices into healthcare systems globally, particularly in Europe and Asia, is contributing significantly to the market expansion. In addition, supportive government policies, greater availability of homeopathic medicines, and the growing presence of specialized clinics strengthen the sector.

The market is divided into several product categories, including dilutions, tinctures, tablets and capsules, granules, creams and ointments, nasal sprays, and others. Among these, the dilutions segment holds the largest share and is expected to grow at a CAGR of 11.9% during the forecast timeframe. This segment's dominance is rooted in the core principles of homeopathy, which use highly diluted substances to stimulate the body's natural healing mechanisms. These remedies are known for their safety and gentle effects, making them appealing to those seeking natural treatments for chronic conditions requiring long-term management.

The U.S. holds a prominent position in the North American homeopathy market and is expected to maintain this lead, with a CAGR of 11.7% in 2023. The demand for alternative treatments is notably driven by the high prevalence of chronic health conditions, especially arthritis, which leads many individuals to seek non-toxic, natural treatment alternatives. The increasing number of people affected by such conditions is further expanding the market for homeopathic remedies, which offer a safe and effective option for managing pain and promoting overall wellness.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$9.3 Billion
Forecast Value$25.4 Billion
CAGR12%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising awareness related to homeopathic treatment options
      • 3.2.1.2 Increasing prevalence of chronic diseases
      • 3.2.1.3 Growing popularity in emerging markets
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Availability of conventional and alternative medicines
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Consumer behaviour analysis
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Dilutions
  • 5.3 Tinctures
  • 5.4 Tablets & capsule
  • 5.5 Granules
  • 5.6 Creams & ointments
  • 5.7 Nasal spray
  • 5.8 Other products

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Analgesic and antipyretic
  • 6.3 Gastroenterology
  • 6.4 Respiratory
  • 6.5 Neurology
  • 6.6 Dermatology
  • 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By Source, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Plant-based
  • 7.3 Mineral-based
  • 7.4 Animal-based

Chapter 8 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prescription
  • 8.3 OTC

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 A Nelson & Co
  • 10.2 Ainsworths
  • 10.3 Bahola
  • 10.4 Biologische Heilmittel
  • 10.5 BJain Pharmaceuticals
  • 10.6 Boiron
  • 10.7 Dr. Willmar Schwabe
  • 10.8 Hahnemann Laboratories
  • 10.9 Heel
  • 10.10 Hevert - Arzneimittel
  • 10.11 Homeocan
  • 10.12 Medisynth
  • 10.13 Powell Laboratories
  • 10.14 SBL
  • 10.15 Wheezal Homoeo Pharma